Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zoetis
ZTS
$31.6B
| $478M | 0.26% |
5,222,310
-187,730
| -3% | -$16.7M |
|
102
Global Payments
GPN
$22.1B
| $478M | 0.26% |
3,752,384
+251,323
| +7% | +$30.2M |
|
103
Intel
INTC
$466B
| $473M | 0.25% |
10,009,233
-4,768,049
| -32% | -$232M |
|
104
AbbVie
ABBV
$458B
| $469M | 0.25% |
4,956,531
-287,425
| -5% | -$27.3M |
|
105
Zurn Elkay Water Solutions
ZWS
$8.07B
| $464M | 0.25% |
31,279,607
-204,914
| -0.7% | -$2.92M |
|
106
Northrop Grumman
NOC
$77B
| $460M | 0.25% |
1,450,744
-209,866
| -13% | -$64M |
|
107
Intuit
INTU
$81.1B
| $460M | 0.25% |
2,022,580
+216,875
| +12% | +$46.6M |
|
108
General Dynamics
GD
$105B
| $449M | 0.24% |
2,193,060
-553,409
| -20% | -$108M |
|
109
Parker-Hannifin
PH
$125B
| $437M | 0.23% |
2,378,193
-163,692
| -6% | -$28.1M |
|
110
Edwards Lifesciences
EW
$47.6B
| $436M | 0.23% |
7,515,384
+4,052,637
| +117% | +$198M |
|
111
Micron Technology
MU
$1.04T
| $430M | 0.23% |
9,500,254
+1,294,408
| +16% | +$65.3M |
|
112
Sysco
SYY
$39.7B
| $428M | 0.23% |
5,837,753
-65,461
| -1% | -$4.72M |
|
113
ASML
ASML
$675B
| $420M | 0.22% |
2,232,660
+86,754
| +4% | +$17.4M |
|
114
Suncor Energy
SU
$77.7B
| $419M | 0.22% |
10,834,741
+427,672
| +4% | +$17.3M |
|
115
3M
MMM
$89B
| $412M | 0.22% |
2,337,832
-642,494
| -22% | -$111M |
|
116
Old Dominion Freight Line
ODFL
$48.5B
| $407M | 0.22% |
7,566,711
+78,774
| +1% | +$3.99M |
|
117
Waters Corp
WAT
$36.8B
| $406M | 0.22% |
2,087,397
+29,978
| +1% | +$5.8M |
|
|
SCHW
118
Charles Schwab
SCHW
$177B
| $403M | 0.22% |
8,193,774
+218,464
| +3% | +$11.2M |
|
119
NRG Energy
NRG
$29.8B
| $398M | 0.21% |
10,650,354
+649,024
| +6% | +$21.8M |
|
|
RTN
120
DELISTED
Raytheon Company
RTN
| $391M | 0.21% |
1,892,661
-151,762
| -7% | -$30.2M |
|
121
Deere & Co
DE
$170B
| $391M | 0.21% |
2,600,253
-271,612
| -9% | -$39M |
|
122
Elevance Health
ELV
$81.9B
| $389M | 0.21% |
1,420,045
+1,457
| +0.1% | +$378K |
|
123
VF Corp
VFC
$6.68B
| $389M | 0.21% |
4,420,644
+725,579
| +20% | +$61.9M |
|
124
Ball Corp
BALL
$17B
| $389M | 0.21% |
8,834,258
+257,164
| +3% | +$10.5M |
|
125
ICU Medical
ICUI
$3.93B
| $388M | 0.21% |
1,370,845
+7,475
| +0.5% | +$2.19M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.